•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
Stifel Makes Strategic Investment in Meow; Partners to Launch Next-Generation Digital Banking Platform
Stifel Financial Schedules Third Quarter Financial Results Conference Call
Morgan Stanley Direct Lending Fund (NYSE:MSDL) vs. Stifel Financial (NYSE:SF) Financial Contrast
Faron Pharmaceuticals keeps Stifel backing ahead of BEXERA test
199,915 Shares in Stifel Financial Corporation $SF Acquired by Argent Capital Management LLC
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
Stifel Financial: Mid-Market Advisory And Commissions Could Resist Hikes
1919 Investment Counsel Recognized Among Barron's 2026 Top 100 RIA Firms
Santhera first-half sales double as Stifel keeps ‘buy' rating and CHF25 target
Stifel Reports August 2026 Operating Data
Stifel Expands Venture Banking Presence Across East Coast With Senior Hires
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $698,000 Position in Stifel Financial Corporation $SF
Amundi Cuts Stock Position in Stifel Financial Corporation $SF
KBW Announces Index Rebalancing for Third-Quarter 2026
Mission Group gets Stifel 'buy' as recovery outpaces valuation
Stifel Deepens Fixed Income Platform with Senior Talent
Canada Pension Plan Investment Board Purchases Shares of 93,950 Stifel Financial Corporation $SF
Stifel Reports July 2026 Operating Data
Stifel reiterates Buy on Faron Pharmaceuticals after cash update secures runway to key trial readout